Taken together, these results demonstrated that the disease progression was dependent on extracellular signaling from senescent microglial cells expressing p16INK4A, posing the premises to develop strategies to halt or revert neurodegenerative diseases. The gene discussed is CDKN2A; the disease is neurodegenerative disease.